Multiple Docetaxel Retreatments Without Prednisone for Metastatic Castration-Resistant Prostate Cancer in the Docetaxel-Only Era: Effects on PSA Kinetics and Survival
Version 2 2021-05-18, 16:24
Version 1 2021-05-18, 16:23
media
posted on 2021-05-18, 16:24 authored by Adis Rapid Journals on behalf of:, Agnieszka Maj-Hes, Tibor Szarvas, Sabina Sevcenco, Gero Kramer<p><strong>Article full
text</strong></p>
<p><br></p><p>
The above summary slide represents the opinions of
the <b>authors</b>. For a full list of declarations, including funding and author
disclosure statements, please see the full text online (see “read the
peer-reviewed publication” opposite). </p>
<p>© The authors, CC-BY-NC <b>2021</b>.<b>
</b></p>
